---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-26-000029"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2026-07-06T12:05:15+00:00"
generated_at: "2026-07-06T12:10:07.500690+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Prestige closes LaCorium acquisition for ~$150M, prices $400M notes at 6.25% due 2034

## Summary
- Completed acquisition of LaCorium Health for ~$150M cash; LaCorium has ~$40M annual revenue, expected ~$12M EBITDA post-synergies.
- Priced $400M senior notes at 6.25% due 2034; proceeds to redeem existing 5.125% notes due 2028.
- Borrowed $95M additional term loans under existing credit agreement to finance part of acquisition.
- Q1 FY2027 earnings results to be released on August 6, 2026, with conference call.

## SEC filing metadata
- accession: 0001295947-26-000029
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2026-07-06T12:05:15+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594726000029/0001295947-26-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594726000029/pbh-20260630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-26-000029
- JSON: https://secwatch.observer/filing/0001295947-26-000029.json
- Plain text: https://secwatch.observer/filing/0001295947-26-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.